Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD)
Clinical trial NCT04081363 · COMPLETED
Trial details
- NCT number
- NCT04081363
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-07
- Primary completion
- 2019-12-21
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.